Response to the submission IJAA-D-21-00195 Hydroxychloroquine + Azithromycin treatment in elderly patients
Published in International Journal of Antimicrobial Agents
Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment
Published in International Journal of Antimicrobial Agents
Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of “goals of care”
Published in International Journal of Antimicrobial Agents
Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects ...
Published in International Journal of Antimicrobial Agents
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
Published in International Journal of Antimicrobial Agents
Hydroxychloroquine lung pharmacokinetics in critically ill patients infected with COVID-19.
...Published in International journal of antimicrobial agents
Different dosage regimens of hydroxychloroquine were used to manage COVID-19 patients, with no information on the lungs' exposure in this population. The aim of our study was to evaluate hydroxychloroquine concentrations in the lung epithelial lining fluid (ELF) in patients infected with COVID-19. This study is a retrospective, observational, multi...
Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
...Published in International Journal of Antimicrobial Agents
Reply to the letter to the editor “Azithromycin, treatment in COVID-19”
Published in International Journal of Antimicrobial Agents
Azithromycin, a questionable treatment for COVID-19
Published in International Journal of Antimicrobial Agents
Response to advances statistical methods and designs for clinical trials for COVID-19.
Published in International journal of antimicrobial agents
